Company intelligence / Profile preview

AgMedica Bioscience

Chatham, Ontario, Canadaagmedica.ca ↗

Ownership: Private
Employees: ~64
Development stage: Phase 3

Overview

Cannabis producer with EU-GMP certification for dried flower and extracts, operating in medical and recreational markets across Canada and internationally[2][8]. Specializes in pharmaceutical-grade cultivation using proprietary genetics and extraction methods[4][5].

Therapeutic areas: Other
Modalities: Plant-derived therapeutics
Industry: Agriculture & AgTech

Drug pipeline

4 assets

PNT2002

Phase 3

Indications: Metastatic castration-resistant prostate cancer

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on AgMedica Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AgMedica Bioscience.

Explore the full profile